F2G Company
F2G is a biopharmaceutical company developing novel therapies for life-threatening fungal infections.
Investors
Founded Date:
1998
Last Funding Type:
Venture - Series Unknown
Headquarters:
Manchester, Manchester, United Kingdom
Investors Number:
18
Employee Number:
11-50
Industry:
PharmTech
Estimated Revenue:
£7 800 000-38 990 000
Last Funding Date:
8/12/2020
Funding Status:
Venture Capital-Backed
Total Funding:
£166 346 439